Granules India gets USFDA nod for overactive bladder treatment capsule
"The US Food and Drug Administration (USFDA) has approved the abbreviated new drug application filed by Granules Pharmaceuticals, Inc, a wholly owned foreign subsidiary of Granules India Ltd, for Trospium Chloride extended-release capsules, 60 mg," the company said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 23, 2020 Category: Pharmaceuticals Source Type: news
Fall/fracture-related healthcare costs and their association with cumulative anticholinergic burden in people with overactive bladder - Lozano-Ortega G, Schermer CR, Walker DR, Szabo SM, Rogula B, Deighton AM, Gooch KL, Campbell NL.
BACKGROUND: Falls/fractures are major causes of morbidity and mortality among older adults and the resulting health consequences generate a substantial economic burden. Risk factors are numerous and include overactive bladder (OAB) and anticholinergic use.... (Source: SafetyLit)
Source: SafetyLit - April 22, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Inpatient'Voiding School' Could Boost Continence in Kids With Refractory Non-neurogenic Overactive Bladder Inpatient'Voiding School' Could Boost Continence in Kids With Refractory Non-neurogenic Overactive Bladder
An inpatient bladder rehabilitation"voiding school" appears to improve day- and night-time incontinence in children with refractory non-neurogenic overactive bladder, researchers from Belgium report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 25, 2020 Category: Consumer Health News Tags: Medscape Today News Source Type: news
New clinical trial examines a potential noninvasive solution for overactive bladders
(University of Southern California - Health Sciences) Keck Medicine of USC urologists are launching a clinical trial to evaluate the effectiveness of spinal cord stimulation in patients with an overactive bladder due to neurological conditions, such as a spinal cord injury or stroke, and idiopathic (unknown) causes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 10, 2020 Category: International Medicine & Public Health Source Type: news
Urovant Sciences Announces U.S. FDA Acceptance of New Drug Application for Vibegron for the Treatment of Overactive Bladder
IRVINE, Calif.& BASEL, Switzerland--(BUSINESS WIRE) March 5, 2020 -- Urovant Sciences (Nasdaq: UROV) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) for... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - March 5, 2020 Category: Drugs & Pharmacology Source Type: news
Millions with bladder weakness may finally be spared embarrassment thanks to 'game-changer' test
Scientists at the University of Portsmouth are a step closer in the development of a 'game-changer' test which will diagnose an overactive bladder quicker, slowing the condition's progression. (Source: the Mail online | Health)
Source: the Mail online | Health - February 20, 2020 Category: Consumer Health News Source Type: news
Wireless device for treating people with overactive bladder
People with an overactive bladder could have a rechargeable wireless device fitted to ease their condition, NICE has said in new draft guidance. (Source: NHS Networks)
Source: NHS Networks - February 17, 2020 Category: UK Health Source Type: news
Ease drug-resistant overactive bladder with wireless device, doctors advised
Can be inserted under skin to stimulate sacral nerve, says NICE Related items fromOnMedica Surgical mesh last resort for prolapse or incontinence Pelvic organ prolapse Strong women ’s rights linked to better health Hundreds of women take legal action over vaginal mesh implants Surgical options must be ‘last resort’ for stress incontinence (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 13, 2020 Category: UK Health Source Type: news
Drug activates brown fat, improves glucose metabolism in healthy women
In a small study, a drug approved to treat overactive bladder boosted brown fat activity and improved glucose metabolism in healthy women. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - February 3, 2020 Category: Consumer Health News Source Type: news
Developing a Nurse Practitioner-Directed OAB Program Developing a Nurse Practitioner-Directed OAB Program
Could an NP-led program help streamline the management of patients with overactive bladder?Urologic Nursing (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 29, 2020 Category: Consumer Health News Tags: Nursing Journal Article Source Type: news
ANI Announces Launch of Tolterodine Extended-Release Capsules
BAUDETTE, Minn., Jan. 24, 2020 -- (Healthcare Sales & Marketing Network) -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Tolterodine Extended-Release Capsules, 2 mg and 4 mg. The current annual U.S. market for... Biopharmaceuticals, Urology, Generics, Product Launch ANI Pharmaceuticals, Tolterodine, overactive bladder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 24, 2020 Category: Pharmaceuticals Source Type: news
Bioelectronic Medicine on the Rise
Bioelectronic medicine could be one of healthcare’s biggest secrets. The space is filled with applications – but many aren’t mainstream yet.
A panel titled “ Bioelectronic Medicine: Redefining Medical Treatment,†will be held Tuesday, February 11, from 2:05 to 3:00 p.m. in Room 210A at MD&M West Anaheim to discuss the space and how it could impact healthcare.
While there have been some significant movements in that time – perhaps one of the greatest has developments has been GlaxoSmithKline teaming up with Verily...
Source: MDDI - January 22, 2020 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Electronics Source Type: news
Using Neuromodulation to Treat Premature Ejaculation
Men’s sexual health and wellness company, Morari Medical is using neuromodulation for its wearable device to help treat premature ejaculation (PE).
The Maple Grove, MN-based company debuted a prototype of the patch-like device at the Consumer Electronics Show in Las Vegas earlier this month. Morari was one of 10 companies in the emerging sextech market to have a presence at the show.
Jeff Bennett, the company’s founder and CEO spoke with MD+DI about the Morari Medical and its mission.
“Specifically, we’re trying to address the medical condition of PE, ...
Source: MDDI - January 20, 2020 Category: Medical Devices Authors: Omar Ford Tags: Electronics Source Type: news
What Works Best to Help Men With Overactive Bladder?
Title: What Works Best to Help Men With Overactive Bladder?Category: Health NewsCreated: 1/14/2020 12:00:00 AMLast Editorial Review: 1/15/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - January 15, 2020 Category: Nutrition Source Type: news
What Works Best to Help Men With Overactive Bladder?
A combination of drugs and behavioral therapy seems to work better than drugs alone, but behavioral therapy alone also worked better than drugs, the researchers found. (Source: WebMD Health)
Source: WebMD Health - January 14, 2020 Category: Consumer Health News Source Type: news
